Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice

被引:46
作者
Rabinovitch, A [1 ]
SuarezPinzon, WL [1 ]
Sorensen, O [1 ]
机构
[1] UNIV ALBERTA, DEPT MED MICROBIOL & IMMUNOL, EDMONTON, AB T6G 2S2, CANADA
基金
英国医学研究理事会;
关键词
NOD mice; insulitis; IL-12; IFN-gamma; IL-2;
D O I
10.1006/jaut.1996.0084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interferon-gamma (IFN-gamma) is implicated as a mediator of islet beta-cell destruction in autoimmune, insulin-dependent diabetes mellitus (IDDM). Because interleukin 12 (IL-12) is a potent inducer of IFN-gamma production, we sought evidence implicating IL-12 in IDDM development. In the present study we used a reverse transcriptase polymerase chain reaction (RT-PCR) assay to measure IL-12 mRNA expression levels in islets from nonobese diabetic (NOD) mice. Expression of mRNA encoding the p40 chain of IL-12 (IL-12 p40) in mononuclear leukocytes isolated from islets of female NOD mice increased progressively from age 5 weeks to diabetes onset (>13 weeks). By contrast, IL-12 p40 mRNA levels were significantly decreased in islet mononuclear leukocytes, but not spleens, from female NOD mice protected from diabetes by administration of complete Freund's adjuvant (CFA) in early life. In addition, mRNA levels of IL-12 p40, IFN-gamma and IL-2 were significantly decreased in syngeneic islet grafts, but not spleens, from female NOD mice protected from diabetes recurrence by CFA administration at the time of islet transplantation. These findings show that IL-12 gene expression in the insulitis lesion correlates with both primary and recurrent diabetes development in NOD mice, possibly via induction of T helper (Th) 1-type cytokines, IL-2 and IFN-gamma. (C) 1996 Academic Press Limited
引用
收藏
页码:645 / 651
页数:7
相关论文
共 32 条
[1]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[2]  
CAMPBELL IL, 1988, J IMMUNOL, V141, P2325
[3]   ESSENTIAL ROLE FOR INTERFERON-GAMMA AND INTERLEUKIN-6 IN AUTOIMMUNE INSULIN-DEPENDENT DIABETES IN NOD/WEHI MICE [J].
CAMPBELL, IL ;
KAY, TWH ;
OXBROW, L ;
HARRISON, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :739-742
[4]  
CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243
[5]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[6]   PREVENTION OF DIABETES IN NOD MICE TREATED WITH ANTIBODY TO MURINE IFN-GAMMA [J].
DEBRAYSACHS, M ;
CARNAUD, C ;
BOITARD, C ;
COHEN, H ;
GRESSER, I ;
BEDOSSA, P ;
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) :237-248
[7]   AN IMPROVED METHOD FOR ISOLATION OF MOUSE PANCREATIC-ISLETS [J].
GOTOH, M ;
MAKI, T ;
KIYOIZUMI, T ;
SATOMI, S ;
MONACO, AP .
TRANSPLANTATION, 1985, 40 (04) :437-438
[8]   ACCELERATION OF DIABETES IN YOUNG NOD MICE WITH A CD4+ ISLET-SPECIFIC T-CELL CLONE [J].
HASKINS, K ;
MCDUFFIE, M .
SCIENCE, 1990, 249 (4975) :1433-1436
[9]   IN-VIVO ACTIVITY AND IN-VITRO SPECIFICITY OF CD4(+) TH1 AND TH2 CELLS DERIVED FROM THE SPLEENS OF DIABETIC NOD MICE [J].
HEALEY, D ;
OZEGBE, P ;
ARDEN, S ;
CHANDLER, P ;
HUTTON, J ;
COOKE, A .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2979-2985
[10]  
JARPE A, 1991, REG IMMUNOL, V3, P305